Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
PointState Capital LP KNX Knight-Swift Transportation Holdings Inc. 13G 5.7% 33d
CVI Investments, Inc. SBFM Sunshine Biopharma Inc. 13G 9.9% 33d
Choo Chee Kong GDTC CytoMed Therapeutics Ltd 13D/A 24.92% 33d
Vivo Opportunity Fund Holdings, L.P. AVBP ArriVent BioPharma, Inc. 13G 5% 33d
Sculptor Capital LP HLXC Helix Acquisition Corp. III 13G 5.23% 33d
JANE STREET GROUP, LLC AEMD Aethlon Medical Inc 13G 5% 33d
Portolan Capital Management, LLC LTRX Lantronix Inc 13G 5.15% 33d
Ramaswamy Vivek ASST Strive, Inc. 13D/A 5.6% 33d
GLENVIEW CAPITAL MANAGEMENT, LLC SGRY Surgery Partners, Inc. 13G 5.4% 33d
Drew Holdings Ltd. BORR Borr Drilling Ltd 13D 12.2% 33d
Tarheel Investors III L.P. ITGR Integer Holdings Corp 13D 14% 33d
Roman Vintfeld PUSA Powerus Corp 13D 8.9% 33d
Michael Sinensky PUSA Powerus Corp 13D 11.6% 33d
JPMORGAN CHASE & CO RGNX REGENXBIO Inc. 13G 5.3% 33d
ROYCE & ASSOCIATES LP BBSI Barrett Business Services Inc 13G/A 4.49% 33d
MILLENNIUM MANAGEMENT LLC AMRC Ameresco, Inc. 13G/A 0.1% 33d
Empery Asset Management, LP OTLK Outlook Therapeutics, Inc. 13G 8.73% 33d
Empery Asset Management, LP CLNN Clene Inc. 13G/A 1.56% 33d
Copeland Capital Management, LLC USPH U S Physical Therapy Inc 13G 6.3% 33d
JPMORGAN CHASE & CO MIDD MIDDLEBY Corp 13G/A 4.5% 33d
Copeland Capital Management, LLC NSSC Napco Security Technologies, Inc 13G 5.8% 33d
Empery Asset Management, LP LTRN Lantern Pharma Inc. 13G/A 4.99% 33d
SPHERA FUNDS MANAGEMENT LTD. TENX Tenax Therapeutics, Inc. 13G/A 7.09% 33d
Peter J Abrahamson UFI Unifi Inc 13G/A 6.8% 33d
JPMORGAN CHASE & CO LXEO Lexeo Therapeutics, Inc. 13G 5.5% 33d
JPMORGAN CHASE & CO HUBS Hubspot Inc 13G 7.3% 33d
MILLENNIUM MANAGEMENT LLC IRTC iRhythm Holdings, Inc. 13G/A 1.1% 33d
Copeland Capital Management, LLC EE Excelerate Energy, Inc. 13G 6.1% 33d
KAO MIN H GRMN Garmin Ltd 13G/A 9.7% 33d
JPMORGAN CHASE & CO HTHT H World Group Ltd 13G 5% 33d
REINHART PARTNERS, LLC. YETI YETI Holdings, Inc. 13G 5.1% 33d
JPMORGAN CHASE & CO ETR Entergy Corp 13G/A 4.4% 33d
JPMORGAN CHASE & CO MANE Veradermics, Inc 13G 5.6% 33d
JPMORGAN CHASE & CO LBRX Lb Pharmaceuticals Inc 13G/A 4.3% 33d
ROYCE & ASSOCIATES LP AVNW Aviat Networks, Inc. 13G/A 4.56% 33d
JPMORGAN CHASE & CO RYTM Rhythm Pharmaceuticals, Inc. 13G 5.1% 33d
Hui Li UCL uCloudlink Group Inc. 13G/A 4.26% 33d
JPMORGAN CHASE & CO KLIC Kulicke & Soffa Industries Inc 13G/A 3.4% 33d
MILLENNIUM MANAGEMENT LLC WW Ww International, Inc. 13G/A 0.4% 33d
WASATCH ADVISORS LP SDHC Smith Douglas Homes Corp. 13G/A 0% 33d
Inflection Point Fund I LP MRLN Merlin, Inc. 13G 9.9% 33d
Bambino 255. V V UG (haftungsbeschrankt) SSM Sono Group N.V. 13G/A 0% 33d
FALLON DOUG BRAG Bragg Gaming Group Inc. 13D/A 4.9% 33d
HBM Healthcare Investments (Cayman) Ltd. VCRE Vicore Pharma Holding AB 13G 8% 33d
REINHART PARTNERS, LLC. AHCO AdaptHealth Corp. 13G/A 0% 33d
Sun Valley Investments AG CRCUF Canagold Resources Ltd. 13D 42.1% 33d
Melco International Development Limited MLCO Melco Resorts & Entertainment LTD 13D/A 62.6% 37d
Sachem Head Capital Management LP SHC Sotera Health Co 13G/A 0% 37d
Zheng Mingjie WBUY Webuy Global Ltd 13D 21.69% 37d
KCM Capital Inc NUAI New ERA Energy & Digital, Inc. 13G/A 10.9% 37d